Latest Content

Survivor Reflects as FDA Approves Monjuvi Combo for Follicular Lymphoma

August 29th 2025, 7:00pm

By Spencer Feldman

Article

The FDA approved Monjuvi with Revlimid and Rituxan for follicular lymphoma, the same combination that brought survivor Troy Anderson a lasting response.

As Fall Approaches: A Season of Color, Faith, and Strength

August 29th 2025, 5:00pm

By Linda Cohen

Article

Autumn lifts my spirit, reminding me to embrace beauty, family, faith, and gratitude even while living with cancer.

Managing Early Menopause and Fertility Concerns During Cancer Care

August 29th 2025, 4:00pm

By Ryan Scott

Article

Dr. Monica Avila explains how cancer treatments can trigger early menopause, causing symptoms like hot flashes, mood changes and irregular periods.

FDA Grants Designations for D3S-001 in KRAS G12C-Mutated Cancers

August 29th 2025, 3:00pm

By Ryan Scott

Article

FDA grants D3S-001 treatment breakthrough therapy for KRAS G12C some with lung cancer and orphan drug status for KRAS G12C colorectal cancer in adults.

A Holistic Look at Emotional Burdens After a Prostate Cancer Diagnosis

August 29th 2025, 1:20pm

By Dr. Brian Keith McNeil

Video

As part of its Speaking Out video series, CURE talked to Dr. Brian Keith McNeil, on behalf of ZERO-End Prostate Cancer, about managing the emotional and mental health impact of prostate cancer for patients and caregivers.

How to Manage Side Effects After Prostate Cancer Treatment

August 29th 2025, 1:15pm

By Dr. Brian Keith McNeil

Video

As part of its Speaking Out video series, CURE talked to Dr. Brian Keith McNeil, on behalf of ZERO-End Prostate Cancer, about managing side effects following prostate cancer treatment.

Prostate Cancer Treatment Evolution: Focus on Patient Quality of Life

August 29th 2025, 1:10pm

By Dr. Brian Keith McNeil

Video

As part of its Speaking Out video series, CURE talked to Dr. Brian Keith McNeil, on behalf of ZERO-End Prostate Cancer, about navigating treatment option in prostate cancer.

Understanding Gleason Score During a Prostate Cancer Diagnosis

August 29th 2025, 1:00pm

By Dr. Brian Keith McNeil

Video

As part of its Speaking Out video series, CURE talked to Dr. Brian Keith McNeil, on behalf of ZERO-End Prostate Cancer, about understanding Gleason Score and prostate cancer risk.

Standing Up to Cancer with Strength and a Positive Mindset

August 28th 2025, 9:00pm

By Linda Cohen

Article

Facing a cancer diagnosis was terrifying, but determination, lifestyle changes, and a strong support system helped me fight and find hope.

Early-Stage Melanoma: Diagnosis, Treatment and Next Steps

August 28th 2025, 8:00pm

By Ryan Scott

Video

Stage 1 melanoma is treatable with surgery, and when combined with early detection, proper care and regular follow-ups, it offers a favorable outlook.

Biology-Guided Radiation Brings Hope After Three Cancer Diagnoses

August 28th 2025, 7:00pm

By Spencer Feldman

Article

Hideko Warner shared how she faced three cancers at once and became the first in Orange County to receive biology-guided radiation therapy with no side effects.

Patient With Stage 4 Lung Cancer Shares How She Uses Social Media

August 28th 2025, 5:00pm

By Ryan Scott

Article

Clara Mae Cirk, a 30-year-old who was diagnosed with stage 4 lung cancer, opens up about her journey and using social media as an outlet to educate others.

FDA Gives Fast Track Designation to Stenoparib in Advanced Ovarian Cancer

August 28th 2025, 4:00pm

By Ryan Scott

Article

The FDA has granted fast track designation to stenoparib, an investigational therapy for patients with advanced ovarian cancer.

Changing Seasons Can Affect A Survivor’s Outlook After Cancer

August 28th 2025, 3:00pm

By Bonnie Annis

Article

The shift in seasons reminds me I’m alive, grateful, and still changing as a cancer survivor embracing life’s new chapters.

Patients With Breast Cancer May Have Fewer Side Effects with ADCs

August 28th 2025, 1:00pm

By Kelsey Martin

Video

Patients with breast cancer receiving antibody-drug conjugates after chemo can generally expect milder side effects compared with their previous treatment.